The function of trophomirs and other micrornas in the human placenta

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 8, 2015, Pages 1-16

  Sadovsky, Yoel ^a,b   Mouillet, Jean Francois ^a   Ouyang, Yingshi ^a   Bayer, Avraham ^a   Coyne, Carolyn B ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; TROPHOBLASTIC MICRORNA; UNCLASSIFIED DRUG; GENETIC MARKER;

ARTICLE; CELL DIFFERENTIATION; EPIGENETICS; EXOSOME; FEMALE; FETUS (ANATOMY); GENOMICS; HUMAN; HUMAN TISSUE; PLACENTA; PLACENTA DISORDER; PLACENTA FUNCTION; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SECRETION (PROCESS); SENSITIVITY AND SPECIFICITY; TROPHOBLAST;

EUTHERIA;

EXOSOMES; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MICRORNAS; PLACENTA; PLACENTA DISEASES; PREGNANCY; SENSITIVITY AND SPECIFICITY; TROPHOBLASTS;

EID: 84938694353     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a023036     Document Type: Article

References (175)

1. Abdelmohsen K, Srikantan S, Tominaga K, Kang MJ, Yaniv Y, Martindale JL, Yang X, Park SS, Becker KG, Subrama nian M, et al. 2012. Growth inhibition by miR-519 via multiple p21-inducing pathways. Mol Cell Biol 32: 2530– 2548.
2. Aharon A, Brenner B. 2013. Placenta-derived microparticles. Thromb Res 131: S22–S24.
3. Ahn K, Gim JA, Ha HS, Han K, Kim HS. 2013. The novel MER transposon-derived miRNAs in human genome. Gene 512: 422–428.
4. Akers JC, Gonda D, Kim R, Carter BS, Chen CC. 2013. Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol 113: 1–11.
5. Anton L, Olarerin-George AO, Schwartz N, Srinivas S, Bastek J, Hogenesch JB, Elovitz MA. 2013. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol 183: 1437–1445.
6. Arck P, Hansen PJ, Mulac Jericevic B, Piccinni MP, Szekeres Bartho J. 2007. Progesterone during pregnancy: Endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol 58: 268–279.
7. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, et al. 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci 108: 5003–5008.
8. Avissar-Whiting M, Veiga KR, Uhl KM, Maccani MA, Gagne LA, Moen EL, Marsit CJ. 2010. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 29: 401–406.
9. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, et al. 2012. Syndecan–syntenin–ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14: 677– 685.
10. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM, et al. 2008. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 26: 2496–2505.
11. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, Einav U, Gilad S, Hurban P, Karov Y, et al. 2004. MicroRNA expression detected by oligonucleotide microarrays: System establishment and expression profiling in human tissues. Genome Res 14: 2486–2494.
12. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281–297.
13. Bayer A, Delorme-Axford E, Sleigher C, Frey TK, Trobaugh DW, Klimstra WB, Emert-Sedlak LA, Smithgall TE, Kinchington PR, Vadia S, et al. 2014. Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am J Obstet Gynecol 211: doi: 10.1016/j.ajog.2014.1007.1060
14. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al. 2005. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766–770.
15. Best JM. 2007. Rubella. Semin Fetal Neonatal Med 12: 182– 192.
16. Bortolin-Cavaille ML, Dance M, Weber M, Cavaille J. 2009. C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res 37: 3464–3473.
17. Buckberry S, Bianco-Miotto T, Roberts CT. 2014. Imprinted and X-linked non-coding RNAs as potential regulators of human placental function. Epigenetics 9: 81–89.
18. Ceccom J, Bourdeaut F, Loukh N, Rigau V, Milin S, Takin R, Richer W, Uro-Coste E, Couturier J, Bertozzi AI, et al. 2014. Embryonal tumor with multilayered rosettes: Diagnostic tools update and review of the literature. Clin Neuropathol 33: 15–22.
19. Chen DB, Wang W. 2013. Human placental microRNAs and preeclampsia. Biol Reprod 88: 130.
20. Chen X, Liang H, Zhang J, Zen K, Zhang CY. 2012. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 22: 125–132.
21. Chi SW, Hannon GJ, Darnell RB. 2012. An alternative mode of microRNA target recognition. Nat Struct Mol Biol 19: 321–327.
22. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. 2008. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482–490.
23. Choi AM, Ryter SW, Levine B. 2013a. Autophagy in human health and disease. N Engl J Med 368: 651–662.
24. Choi SY, Yun J, Lee OJ, Han HS, Yeo MK, Lee MA, Suh KS. 2013b. MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta 34: 799–804.
25. Cindrova-Davies T, Herrera EA, Niu Y, Kingdom J, Giussani DA, Burton GJ. 2013. Reduced cystathionine g-Lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: Hydrogen sulfide as a placental vasodilator. Am J Pathol 182: 1448–1458.
26. Colleoni F, Padmanabhan N, Yung HW, Watson ED, Cetin I, Tissot van Patot MC, Burton GJ, Murray AJ. 2013. Suppression of mitochondrial electron transport chain function in the hypoxic human placenta: A role for miRNA-210 and protein synthesis inhibition. PLoS ONE 8: e55194.
27. Colombo M, Moita C, van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita LF, Thery C, Raposo G. 2013. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126: 5553–5565.
28. Cullen BR, Cherry S, tenOever BR. 2013. Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 14: 374–378.
29. Dai Y, Diao Z, Sun H, Li R, Qiu Z, Hu Y. 2011. MicroRNA 155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides. Hum Reprod 26: 1882–1891.
30. Dai Y, Qiu Z, Diao Z, Shen L, Xue P, Sun H, Hu Y. 2012. MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. Placenta 33: 824– 829.
31. Delorme-Axford E, Donker RB, Mouillet JF, Chu T, Bayer A, Ouyang Y, Wang T, Stolz DB, Sarkar SN, Morelli AE, et al. 2013a. Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci 110: 12048– 12053.
32. Delorme-Axford E, Bayer A, Sadovsky Y, Coyne CB. 2013b. Autophagy as a mechanism of antiviral defense at the maternal fetal interface. Autophagy 9: 2173–2174.
33. Ding SW. 2010. RNA-based antiviral immunity. Nat Rev Immunol 10: 632–644.
34. Donker RB, Mouillet JF, Chu T, Hubel CA, Stolz DB, Morelli AE, Sadovsky Y. 2012. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod 18: 417–424.
35. Doridot L, Miralles F, Barbaux S, Vaiman D. 2013. Trophoblasts, invasion, and microRNA. Front Genet 4: 248.
36. Doridot L, Houry D, Gaillard H, Chelbi ST, Barbaux S, Vaiman D. 2014. miR-34a expression, epigenetic regulation, and function in human placental diseases. Epigenetics 9: 142–151.
37. Duff P, Sweet RL, Edwards RK. 2009. Maternal and fetal infections. In Creasy and Resnik’s maternal fetal medicine (ed. Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR), pp. 739–798. Saunders-Elsevier, Philadelphia.
38. El Andaloussi S, Mager I, Breakefield XO, Wood MJ. 2013. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12: 347–357.
39. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA. 2011. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 204: 178.e112–178.e121.
40. Ergaz Z, Ornoy A. 2006. Parvovirus B19 in pregnancy. Reprod Toxicol 21: 421–435.
41. Esteller M. 2011. Non-coding RNAs in human disease. Nat Rev Genet 12: 861–874.
42. Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, Jeong SH, Walker C, Lanford RE, Lemon SM. 2013. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496: 367–371.
43. Flor I, Bullerdiek J. 2012. The dark side of a success story: MicroRNAs of the C19MC cluster in human tumours. J Pathol 227: 270–274.
44. Flor I, Neumann A, Freter C, Helmke BM, Langenbuch M, Rippe V, Bullerdiek J. 2012. Abundant expression and hemimethylation of C19MC in cell cultures from placenta-derived stromal cells. Biochem Biophys Res Commun 422: 411–416.
45. Forbes K, Farrokhnia F, Aplin JD, Westwood M. 2012. Dicerdependent miRNAs provide an endogenous restraint on cytotrophoblast proliferation. Placenta 33: 581–585.
46. Fu G, Ye G, Nadeem L, Ji L, Manchanda T, Wang Y, Zhao Y, Qiao J, Wang YL, Lye S, et al. 2013a. MicroRNA-376c impairs transforming growth factor-b and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension 61: 864–872.
47. Fu G, Brkic J, Hayder H, Peng C. 2013b. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci 14: 5519–5544.
48. Fukunaga R, Han BW, Hung JH, Xu J, Weng Z, Zamore PD. 2012. Dicer partner proteins tune the length of mature miRNAs in flies and mammals. Cell 151: 533–546.
49. Gabory A, Jammes H, Dandolo L. 2010. The H19 locus: Role of an imprinted non-coding RNA in growth and development. Bioessays 32: 473–480.
50. Gao WL, Liu M, Yang Y, Yang H, Liao Q, Bai Y, Li YX, Li D, Peng C, Wang YL. 2012. The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1). RNA Biol 9: 1002–1010.
51. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, et al. 2008. Serum microRNAs are promising novel biomarkers. PLoS ONE 3: e3148.
52. Gu Y, Sun J, Groome LJ, Wang Y. 2013. Differential miRNA expression profiles between the first and third trimester human placentas. Am J Physiol Endocrinol Metab 304: E836–E843.
53. Gunel T, Zeybek YG, Akcakaya P, Kalelioglu I, Benian A, Ermis H, Aydinli K. 2011. Serum microRNA expression in pregnancies with preeclampsia. Genet Mol Res 10: 4034–4040.
54. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835–840.
55. Guo L, Tsai SQ, Hardison NE, James AH, Motsinger-Reif AA, Thames B, Stone EA, Deng C, Piedrahita JA. 2013. Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas. Placenta 34: 599–605.
56. Hanson PI, Cashikar A. 2012. Multivesicular body morphogenesis. Annu Rev Cell Dev Biol 28: 337–362.
57. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. 1993. Tumour-suppressor activity of H19 RNA. Nature 365: 764–767.
58. 0 terminal and seed regions is correlated with experimentally observed miRNA-mediated silencing efficacy. Sci Rep 2: 996.
59. Higashijima A, Miura K, Mishima H, Kinoshita A, Jo O, Abe S, Hasegawa Y, Miura S, Yamasaki K, Yoshida A, et al. 2013. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. Prenat Diagn 33: 214–222.
60. Hoffman Y, Dahary D, Bublik DR, Oren M, Pilpel Y. 2013. The majority of endogenous microRNA targets within Alu elements avoid the microRNA machinery. Bioinformatics 29: 894–902.
61. Hromadnikova I, Kotlabova K, Doucha J, Dlouha K, Krofta L. 2012. Absolute and relative quantification of placentaspecific microRNAs in maternal circulation with placental insufficiency-related complications. J Mol Diagn 14: 160–167.
62. Hu Y, Li P, Hao S, Liu L, Zhao J, Hou Y. 2009. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47: 923–929.
63. Huang X, Le QT, Giaccia AJ. 2010. MiR-210—Micromanager of the hypoxia pathway. Trends Mol Med 16: 230– 237.
64. Huang L, Shen Z, Xu Q, Huang X, Chen Q, Li D. 2013. Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction. Placenta 34: 624–627.
65. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. 2001. A cellular function for the RNAinterference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834–838.
66. Ishibashi O, Ohkuchi A, Ali MM, Kurashina R, Luo SS, Ishikawa T, Takizawa T, Hirashima C, Takahashi K, Migita M, et al. 2012. Hydroxysteroid (17-b) dehydrogenase 1 is dysregulated by MiR-210 and MiR-518c that are aberrantly expressed in preeclamptic placentas: A novel marker for predicting preeclampsia. Hypertension 59: 265–273.
67. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. 2002. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186: 158–166.
68. Jaskiewicz L, Filipowicz W. 2008. Role of Dicer in posttranscriptional RNA silencing. Curr Top Microbiol Immunol 320: 77–97.
69. Kaplan C. 1993. The placenta and viral infections. Semin Diagn Pathol 10: 232–250.
70. Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G, Reik W. 2012. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 14: 659–665.
71. Kleinrouweler CE, van Uitert M, Moerland PD, Ris-Stalpers C, van der Post JA, Afink GB. 2013. Differentially expressed genes in the pre-eclamptic placenta: A systematic review and meta-analysis. PLoS ONE 8: e68991.
72. Koh W, Pan W, Gawad C, Fan HC, Kerchner GA, Wyss-Coray T, Blumenfeld YJ, El-Sayed YY, Quake SR. 2014. Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci 111: 7361– 7366.
73. Kopriva SE, Chiasson VL, Mitchell BM, Chatterjee P. 2013. TLR3-induced placental miR-210 down-regulates the STAT6/interleukin-4 pathway. PLoS ONE 8: e67760.
74. Kosik KS. 2013. Molecular biology: Circles reshape the RNA world. Nature 495: 322–324.
75. Kotlabova K, Doucha J, Hromadnikova I. 2011. Placentalspecific microRNA in maternal circulation—Identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 89: 185– 191.
76. Krol J, Loedige I, Filipowicz W. 2010. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597–610.
77. Kumar P, Luo Y, Tudela C, Alexander JM, Mendelson CR. 2013. The c-Myc-regulated microRNA-17~92 (miR17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol 33: 1782–1796.
78. Laurent LC, Chen J, Ulitsky I, Mueller FJ, Lu C, Shamir R, Fan JB, Loring JF. 2008. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells 26: 1506–1516.
79. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415– 419.
80. Lee DC, Romero R, Kim JS, Tarca AL, Montenegro D, Pineles BL, Kim E, Lee J, Kim SY, Draghici S, et al. 2011. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: Siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies. Am J Pathol 179: 590–602.
81. Lehnert S, Van Loo P, Thilakarathne PJ, Marynen P, Verbeke G, Schuit FC. 2009. Evidence for co-evolution between human microRNAs and Alu-repeats. PLoS ONE 4: e4456.
82. Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Collins VP, Van Meter T, Picard D, Zhou L, et al. 2009. Frequent amplification of a chr19q13.41 microRNA polycistron (C19MC) in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16: 533–546.
83. Li P, Guo W, Du L, Zhao J, Wang Y, Liu L, Hu Y, Hou Y. 2013a. microRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin Sci (Lond) 124: 27–40.
84. Li Y, Lu J, Han Y, Fan X, Ding SW. 2013b. RNA interference functions as an antiviral immunity mechanism in mammals. Science 342: 231–234.
85. Liang Y, Ridzon D, Wong L, Chen C. 2007. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166.
86. Liu RF, Xu X, Huang J, Fei QL, Chen F, Li YD, Han ZG. 2013. Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2. Cancer Lett 329: 164–173.
87. Longman RE, Johnson TR. 2007. Viral respiratory disease in pregnancy. Curr Opin Obstet Gynecol 19: 120–125.
88. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, et al. 2009. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 81: 717–729.
89. Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E, Dunk C, Lye S, Peng C. 2012. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci 125: 3124–3132.
90. Maccani MA, Marsit CJ. 2011. Exposure and fetal growthassociated miRNA alterations in the human placenta. Clin Epigenetics 2: 401–404.
91. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, Marsit CJ. 2010. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 5: 583–589.
92. Maccani MA, Padbury JF, Marsit CJ. 2011. miR-16 and miR 21 expression in the placenta is associated with fetal growth. PLoS ONE 6: e21210.
93. Maccani MA, Padbury JF, Lester BM, Knopik VS, Marsit CJ. 2013. Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr Res 74: 272–278.
94. Machlin ES, Sarnow P, Sagan SM. 2012. Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids. Curr Gene Ther 12: 301–306.
95. Maillard PV, Ciaudo C, Marchais A, Li Y, Jay F, Ding SW, Voinnet O. 2013. Antiviral RNA interference in mammalian cells. Science 342: 235–238.
96. Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe M, Abdelmohsen K. 2010. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging (Albany NY) 2: 333–343.
97. Maron JL, Johnson KL, Slonim D, Lai CQ, Ramoni M, Alterovitz G, Jarrah Z, Yang Z, Bianchi DW. 2007. Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest 117: 3007–3019.
98. Marraffini LA, Sontheimer EJ. 2010. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 11: 181–190.
99. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. 2002. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110: 563–574.
100. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD. 2005. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123: 607–620.
101. Mayhew TM. 2014. Turnover of human villous trophoblast in normal pregnancy: What do we know and what do we need to know? Placenta 35: 229–240.
102. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. 2011. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 18: 46–56.
103. Meckes DG Jr, Raab-Traub N. 2011. Microvesicles and viral infection. J Virol 85: 12844–12854.
104. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 105: 10513–10518.
105. Mittelbrunn M, Sanchez-Madrid F. 2012. Intercellular communication: Diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol 13: 328–335.
106. Miura K, Miura S, Yamasaki K, Higashijima A, Kinoshita A, Yoshiura K, Masuzaki H. 2010. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 56: 1767–1771.
107. Miura K, Hasegawa Y, Abe S, Higashijima A, Miura S, Mishima H, Kinoshita A, Kaneuchi M, Yoshiura K, Masuzaki H. 2014. Clinical applications of analysis of plasma circulating complete hydatidiform mole pregnancy-associated miRNAs in gestational trophoblastic neoplasia: A preliminary investigation. Placenta. 35: 787–789.
108. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, et al. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756–766.
109. Mor G, Cardenas I. 2010. The immune system in pregnancy: A unique complexity. Am J Reprod Immunol 63: 425–433.
110. Morales-Prieto DM, Chaiwangyen W, Ospina-Prieto S, Schneider U, Herrmann J, Gruhn B, Markert UR. 2012. MicroRNA expression profiles of trophoblastic cells. Placenta 33: 725–734.
111. Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, Schoenleben M, Markert UR. 2013. Pregnancy-associated miRNA-clusters. J Reprod Immunol 97: 51–61.
112. Morin RD, O’Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, et al. 2008. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18: 610–621.
113. Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y. 2010a. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 24: 2030–2039.
114. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, Sadovsky Y. 2010b. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31: 781–784.
115. Mouillet JF, Donker RB, Mishima T, Cronqvist T, Chu T, Sadovsky Y. 2013. The unique expression and function of miR-424 in human placental trophoblasts. Biol Reprod 89: 25.
116. Mouillet JF, Ouyang Y, Bayer A, Coyne CB, Sadovsky Y. 2014. The role of trophoblastic microRNAs in placental viral infection. Int J Dev Biol 58: 281–289.
117. Moya PR, Wendland JR, Salemme J, Fried RL, Murphy DL. 2013. miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells. Int J Neuropsychopharmacol 16: 621–629.
118. Mraz M, Malinova K, Mayer J, Pospisilova S. 2009. Micro RNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 390: 1–4.
119. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L. 2012. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33: 816– 823.
120. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM. 2003. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci 100: 4748–4753.
121. Nigro G, Adler SP, La Torre R, Best AM. 2005. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353: 1350–1362.
122. Noguer-Dance M, Abu-Amero S, Al-Khtib M, Lefevre A, Coullin P, Moore GE, Cavaille J. 2010. The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet 19: 3566–3582.
123. Nykanen A, Haley B, Zamore PD. 2001. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107: 309–321.
124. O’Loughlin AJ, Woffindale CA, Wood MJ. 2012. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 12: 262–274.
125. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, et al. 2010. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12: 19–30; sup pp. 11–13.
126. Ouyang Y, Mouillet JF, Coyne CB, Sadovsky Y. 2014. Review: Placenta-specific microRNAs in exosomes—Good things come in nano-packages. Placenta 35: S69–S73.
127. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, et al. 2012. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18: 883–891.
128. Perron MP, Provost P. 2009. Protein components of the microRNA pathway and human diseases. Methods Mol Biol 487: 369–385.
129. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P, et al. 2007. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196: 261.e1–261.e6.
130. Poon LL, Leung TN, Lau TK, Lo YM. 2000. Presence of fetal RNA in maternal plasma. Clin Chem 46: 1832–1834.
131. Ramakrishnaiah V, Thumann C, Fofana I, Habersetzer F, Pan Q, de Ruiter PE, Willemsen R, Demmers JA, Stalin Raj V, Jenster G, et al. 2013. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci 110: 13109–13113.
132. Raposo G, Stoorvogel W. 2013. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200: 373– 383.
133. Record M. 2014. Intercellular communication by exosomes in placenta: A possible role in cell fusion? Placenta 35: 297–302.
134. Redman CW, Sargent IL. 2008. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 29: S73– S77.
135. Redman CW, Tannetta DS, Dragovic RA, Gardiner C, Southcombe JH, Collett GP, Sargent IL. 2012. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 33: S48–S54.
136. Ren J, Jin P, Wang E, Marincola FM, Stroncek DF. 2009. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 7: 20.
137. Rippe V, Dittberner L, Lorenz VN, Drieschner N, Nimzyk R, Sendt W, Junker K, Belge G, Bullerdiek J. 2010. The two stem cell microRNA gene clusters C19MC and miR-371– 3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS ONE 5: e9485.
138. Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y, Hibi T. 2009. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 28: 2738–2744.
139. Scita G, Di Fiore PP. 2010. The endocytic matrix. Nature 463: 464–473.
140. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J. 2004. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 14: 1741–1748.
141. Shalgi R, Pilpel Y, Oren M. 2010. Repression of transposableelements—A microRNA anti-cancer defense mechanism? Trends Genet 26: 253–259.
142. Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, Du Y, Wang Y, Chang WC, Chen CH, et al. 2013. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497: 383– 387.
143. Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, et al. 2010. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 19: 935–950.
144. Tang Q, Wu W, Xu X, Huang L, Gao Q, Chen H, Sun H, Xia Y, Sha J, Wang X, et al. 2013. miR-141 contributes to fetal growth restriction by regulating PLAG1 expression. PLoS ONE 8: e58737.
145. Tay Y, Rinn J, Pandolfi PP. 2014. The multilayered complexity of ceRNA crosstalk and competition. Nature 505: 344–352.
146. tenOever BR. 2013. RNA viruses and the host microRNA machinery. Nat Rev Microbiol 11: 169–180.
147. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319: 1244–1247.
148. Tsai KW, Kao HW, Chen HC, Chen SJ, Lin WC. 2009. Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells. Epigenetics 4: 587–592.
149. Tsutsumi A, Kawamata T, Izumi N, Seitz H, Tomari Y. 2011. Recognition of the pre-miRNA structure by Drosophila Dicer-1. Nat Struct Mol Biol 18: 1153–1158.
150. Umemura K, Ishioka S, Endo T, Ezaka Y, Takahashi M, Saito T. 2013. Roles of microRNA-34a in the pathogenesis of placenta accreta. J Obstet Gynaecol Res 39: 67–74.
151. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654–659.
152. van Rooij E, Marshall WS, Olson EN. 2008. Toward micro RNA-based therapeutics for heart disease: The sense in antisense. Circ Res 103: 919–928.
153. Ventura W, Koide K, Hori K, Yotsumoto J, Sekizawa A, Saito H, Okai T. 2013. Placental expression of microRNA-17 and -19b is down-regulated in early pregnancy loss. Eur J Obstet Gynecol Reprod Biol 169: 28–32.
154. Vickers KC, Remaley AT. 2012. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 23: 91–97.
155. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13: 423–433.
156. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. 2010. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38: 7248–7259.
157. Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, Parast M, Zheng J, Chen DB. 2012. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 97: E1051– E1059.
158. Wang D, Na Q, Song WW, Song GY. 2014. Altered expression of miR-518b and miR-519a in the placenta is associated with low fetal birth weight. Am J Perinatol 31: 729–734.
159. Whitehead CL, Teh WT, Walker SP, Leung C, Larmour L, Tong S. 2013. Circulating microRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS ONE 8: e78487.
160. Wiedenheft B, Sternberg SH, Doudna JA. 2012. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331–338.
161. Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, Tuschl T. 2013. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci 110: 4255–4260.
162. Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z, Wang H. 2012. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction 143: 389– 397.
163. Xie L, Mouillet JF, Chu T, Parks WT, Sadovsky E, Knofler M, Sadovsky Y. 2014. C19MC microRNAs regulate the migration of human trophoblasts. Endocrinology 155: 4975–4985.
164. Xu L, Yang BF, Ai J. 2013. MicroRNA transport: A new way in cell communication. J Cell Physiol 228: 1713–1719.
165. Xu P, Zhao Y, Liu M, Wang Y, Wang H, Li YX, Zhu X, Yao Y, Wang H, Qiao J, et al. 2014. Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension 63: 1276–1284.
166. 0 -untranslated region on AP-1/NF-kB pathway in HTR8/SVneo cells. Placenta 34: 650–656.
167. Yan T, Cui K, Huang X, Ding S, Zheng Y, Luo Q, Liu X, Zou L. 2014. Assessment of therapeutic efficacy of miR-126 with contrast-enhanced ultrasound in preeclampsia rats. Placenta 35: 23–29.
168. Yang Q, Lu J, Wang S, Li H, Ge Q, Lu Z. 2011. Application of next-generation sequencing technology to profile the cir culating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta 412: 2167– 2173.
169. Zhang R, Wang YQ, Su B. 2008. Molecular evolution of a primate-specific microRNA family. Mol Biol Evol 25: 1493–1502.
170. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, Xin H, Sun S. 2012. Elevated levels of hypoxia-inducible microRNA210 in pre-eclampsia: New insights into molecular mechanisms for the disease. J Cell Mol Med 16: 249–259.
171. Zhao C, Dong J, Jiang T, Shi Z, Yu B, Zhu Y, Chen D, Xu J, Huo R, Dai J, et al. 2011. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS ONE 6: e23925.
172. Zhao Z, Zhao Q, Warrick J, Lockwood CM, Woodworth A, Moley KH, Gronowski AM. 2012. Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem 58: 896–905.
173. Zhao Z, Moley KH, Gronowski AM. 2013. Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases. Clin Biochem 46: 953–960.
174. Zheng Y, Campbell EC, Lucocq J, Riches A, Powis SJ. 2013. Monitoring the Rab27 associated exosome pathway using nanoparticle tracking analysis. Exp Cell Res 319: 1706– 1713.
175. Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ. 2009. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200: e661–e667.